HR Execs on the Move

Specific Diagnostics

www.specific.com

 
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
David Barreca
Vice President of Sales Profile

Similar Companies

Chase Ergonomics

Chase Ergonomics Inc. is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

NewScience

NewScience is a Canton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pedigo Products Inc

Pedigo is the premier manufacturer of stainless steel and chrome equipment for the healthcare industry. With over 60 years of experience in manufacturing and healthcare equipment sales, we have innovated a number of products and concepts that bring

Phonic Ear

Phonic Ear is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Repro Med Systems

Repro-Med Systems, Inc., operating as RMS Medical products, is a leading developer and manufacturer of medical devices and supplies. Repro-Med was incorporated in March, 1980. Its stock is publicly traded in the over-the-counter market and is quoted through the National Daily Quotation Service. Its stock symbol is REPR. The company maintains offices, manufacturing facilities, and warehouse space in Chester, New York. Devices and supplies manufactured and sold by RMS Medical Products are subject to Food and Drug Administration regulation. Our manufacturing facilities and record-keeping must meet FDA standards, and are subject to periodic FDA inspection. In addition, the company's plant is certified by the appropriate ISO international standards for quality in product development, manufacturing, distribution and customer support of its medical devices. RMS manufactures medical devices used in emergency care, hospital settings, nursing homes, other medical facilities and home care. The Company's principal products are the FREEDOM60 Syringe Infusion System and the RES-Q-VAC Emergency Medical Suction System. In 2011, the company received FDA approval to market in the U.S. it's HIgH-Flo RMS Subcutaneous Needle Sets. Since 1986, the company has owned and marketed the Gyneco product line which includes the Masterson Endometrial Biopsy Kit used for in-office biopsy sampling procedures, and the Thermal Cautery System used for tubal ligation procedures. RMS maintains its own sales staff in addition to selling its products through distributors in the U.S. and many other countries. It regularly exhibits at both national and international trade shows. The company holds a number of patents related to products it has developed and is manufacturing. Because Repro-Med Systems, Inc., is a public company, it must comply with financial reporting and other regulations established by the Securities and Exchange Commission.